If possible, women at risk of depression should be identified during pregnancy. They often do not spontaneously seek help. early intervention is important for the health of the woman and her baby. Psychological interventions such as support groups are often helpful. Involving the woman's partner can also assist. Antidepressants are required in some cases and women with psychotic symptoms need urgent psychiatric assessment and treatment.
Introduction
Postnatal depression is better termed perinatal depression as it often begins antenatally, although it may not be recognised until the postnatal period. It is a common disorder, with milder adjustment problems and anxiety affecting some 30% of women while about 15% of women have more significant mood disorders, often with anxiety. Women are reluctant to seek help, but early identification and intervention are essential to minimise the long-term complications. These include suicide, chronic depression and marital difficulties, and for the child, cognitive, emotional and behavioural problems.
Identification
Unless women have previously had depression, they rarely recognise it in themselves during the perinatal period. For most, this is their first episode of depression and is unexpected at a time that is anticipated positively. In the antenatal period it is all put down to 'the pregnancy' with the presumption that everything will resolve itself after the baby is born. Historically, pregnancy was thought to be protective against mental illness and suicide, however this is not the case. Mental illness is just less likely to be recognised in pregnancy. Postnatally, there are many reasons why women do not seek help, or at least not for themselves. These include the presence of predominant anxiety rather than depression, a mistaken belief that postnatal depression is somehow linked to not wanting the baby or being a bad mother, the stigma of being seen as a bad mother and the stigma of depression.
Women seek help for the baby, not for themselves. The long waiting lists in mother and baby units and settling facilities are testimony to the very real problem perceived by mothers of their babies having sleeping and feeding difficulties. In some cases this is the primary problem, but often it is the mother's reaction, her high unrealistic expectations and her own depression and anxiety that are the underlying issue.
A key factor in identifying depression is having a suspicion for the condition particularly in women with risk factors (Box 1).
Ideally, this risk should be detected during pregnancy. 
Psychosocial interventions
While postpartum psychosis (a probable variant of bipolar disorders) may have a clear biological aetiology, perinatal depression appears to begin at least as a stress response, in someone predisposed through personality or genetics. While the end result may be biological changes that will respond to medication, unless the stress is dealt with, recovery is likely to be delayed or prevented. In many cases, stress reduces as the baby ages, becomes more predictable, and life develops a routine. Women can be helped as they adapt to their new lifestyle. They need an opportunity to talk about their feelings and experiences. Although there are common themes, they will vary among women. For some a traumatic birth may be an issue, for others not being 'in control' or loss of lifestyle may be crucial to their feelings.
Therapeutic groups can be effective 3 , but new mother groups can be counterproductive with depressed women feeling they are failures compared to the 'normal' mothers around them.
A specific group can target the common anxieties of these 
Antidepressants in pregnancy
There are risks with antidepressants in pregnancy 5, 6 , but it is important to balance these largely unknown and seeming relatively low risks with the risks of not treating depression.
Anxiety and depression in pregnancy can affect the fetus, for example a higher cortisol concentration at birth can be maintained for 10 years. 7 Depressed women are also more likely to smoke, and have poor nutrition and a risk of suicide.
Box 2 When to consider use of antidepressants for perinatal depression
Severe or significant number of symptoms, particularly biological symptoms (e.g. sleep and appetite disturbance)
Persistent symptoms
Response to psychosocial management nil or inadequate Unable to offer psychosocial management because of cost, distance, or other practical factors Family or past history of good response to medication Woman's preference
Antidepressants in lactation
The harmful effect of taking antidepressants during lactation needs to be balanced against the benefits for each woman. 6, 8 For some women being given permission to cease breastfeeding can be a relief, particularly when anxiety has resulted in decreased milk supply or care of the baby is overwhelming. The risks of antidepressant drugs seem quite low, with the exception of venlafaxine, which appears to be concentrated in the breast milk. Smaller, premature and unwell infants could be more at risk and any subtle effects of drugs in breast milk are unknown.
mother-infant interaction
There is now extensive literature on the association of maternal depression with an increased risk of poorer mental health outcomes in children. 9, 10 While this is clear, the association is not straightforward, and includes a biological influence through genes and stress hormones in pregnancy, as well as the mother's own parenting, her attachment to the child, and her social circumstances.
Research suggests that treating the depression alone does not in itself bring about change in the mother-infant relationship. 
When to refer
While most women with perinatal depression can be managed in general practice, referrals can be considered in a number of key situations. Firstly, if there are risks of harm, referral should be made urgently to a parent-infant unit, psychiatric hospital or crisis team depending on local availability and protocol.
An opinion from a psychiatrist specialising in the area can be particularly useful when medication is being contemplated in pregnancy and lactation.
A psychiatry referral for a management plan (Medicare item 291) can be considered when women have not responded to psychosocial management and at least one antidepressant, or when they have not improved and are reluctant to use antidepressants. Referral to a psychologist is also useful in this scenario, and when anxiety is a key feature.
Referral for assessment, or for ongoing care, should be considered for women with comorbid disorders, significant impairment in the mother-infant interaction and where the mother's childhood issues and personality factors are contributing significantly to presentation and poor progress. The book discusses the mechanisms and pathophysiology of pain, followed by both general and specific information about pharmacology. Non-pharmacological methods are also covered in some detail. Guidelines are provided for assessing pain (including pain in children), managing chronic pain and for a range of specific clinical situations. Despite its compact size, the book is very comprehensive and covers a wide range of situations where pain will need to be assessed and managed. Although much will be very familiar to experienced practitioners, there is still value in reviewing basic knowledge, especially when that knowledge has been added to in the recent past. This book would be invaluable for students and junior doctors, and is likely to be helpful for rural practitioners, given the very wide range of clinical scenarios that they will encounter. It will also be helpful for those who find that the management of chronic pain is becoming more prominent in their day-to-day practice. In short, a useful update of a trusted tool.
Conclusion

